CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
5 hedge funds and large institutions have $18.9M invested in Celyad Oncology SA American Depositary Shares in 2017 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$396K |
| 2 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
+$6K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$621 |
Top Sellers
| 1 |
Victory Capital Management
San Antonio,
Texas
|
-$2.65M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$21.6K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Victory Capital Management
San Antonio,
Texas
| $18.2M | -$2.65M | -47,280 | -13% |
|
|
2
Morgan Stanley
New York
| $597K | +$396K | +7,006 | +197% |
|
|
3
UBS Group
Zurich,
Switzerland
| $49K | -$21.6K | -384 | -31% |
|
|
4
Zurich Cantonal Bank
Zurich,
Switzerland
| $6K | +$6K | +100 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $2K | +$621 | +9 | +45% |
|